GML and infection: The intensity of anti-N antibody labeling of rHEP5.0-GctL-mRFP-infected cells was higher than that of rHEP5.0-CVSG-mRFP-infected cells, and the intensity of anti-N antibody labeling of rHEP5.0-GML-mRFP-infected cells was higher than that of rHEP5.0-CVSG-mRFP- and rHEP5.0-GctL-mRFP-infected cells (p < 0.0001, one-way ANOVA; post-hoc t-test, Bonferroni-corrected, p < 0.0033 for rHEP5.0-CVSG-mRFP infection vs rHEP5.0-GctL-mRFP infection, p < 0.00033 for rHEP5.0-CVSG-mRFP infection vs rHEP5.0-GML-mRFP infection, and rHEP5.0-GctL-mRFP infection vs rHEP5.0-GML-mRFP infection).